ABVC Biopharma Inc
NASDAQ:ABVC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
ABVC Biopharma Inc (ABVC) under the Base Case is 0.0003 USD per share.
Compared with the current market price of 0.8663 USD, the stock appears
Overvalued by 100% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What ABVC Biopharma Does
ABVC Biopharma is a drug-development company that focuses on plant-based medicines. It works on turning natural compounds into prescription drug candidates, with a big emphasis on therapies for brain and nervous system conditions, cancer-related uses, and eye diseases. The company is not a mass-market drug seller; it is mainly a development-stage biotech that builds candidates, tests them, and tries to advance them through the regulatory process.
- Headquarters
- United States of America US
- Employees
- 19
- IPO date
- Nov 9, 2004
Balance Sheet
Continue ABVC Research
Decided on ABVC Biopharma? Get an email when ABVC reaches the price you’d buy at. Free with an account.
What is the Intrinsic Value of one ABVC stock?
The intrinsic value for
ABVC Biopharma Inc (ABVC) under the Base Case is 0.0003 USD.
Is ABVC stock undervalued or overvalued?
Compared with the current market price of 0.8663 USD, the stock appears Overvalued by 100% .